These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15177304)

  • 1. The synergistic effect of adenosine A2A receptors agonist, type IV phosphodiestease inhibitor and ATP-sensitive K channels activation on free radicals production and aggregation of human polymorphoneuclear leukocytes.
    Al-Ayadhi LY; Al-Tuwajri AS
    Pharmacol Res; 2004 Aug; 50(2):157-63. PubMed ID: 15177304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition.
    Okusa MD; Linden J; Huang L; Rosin DL; Smith DF; Sullivan G
    Kidney Int; 2001 Jun; 59(6):2114-25. PubMed ID: 11380813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD.
    Jones NA; Leport M; Holand T; Vos T; Morgan M; Fink M; Pruniaux MP; Berthelier C; O'Connor BJ; Bertrand C; Page CP
    Pulm Pharmacol Ther; 2007; 20(1):60-8. PubMed ID: 16427796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and levcromakalim.
    Cortijo J; Villagrasa V; Navarrete C; Sanz C; Berto L; Michel A; Bonnet PA; Morcillo EJ
    Br J Pharmacol; 1996 Sep; 119(1):99-106. PubMed ID: 8872362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram.
    Sullivan GW; Linden J; Buster BL; Scheld WM
    J Infect Dis; 1999 Nov; 180(5):1550-60. PubMed ID: 10515815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of phosphodiesterase IV during desensitization of the A2A adenosine receptor-mediated cyclic AMP response in rat pheochromocytoma (PC12) cells.
    Chang YH; Conti M; Lee YC; Lai HL; Ching YH; Chern Y
    J Neurochem; 1997 Sep; 69(3):1300-9. PubMed ID: 9282956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4.
    Blease K; Burke-Gaffney A; Hellewell PG
    Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.
    Glover DK; Riou LM; Ruiz M; Sullivan GW; Linden J; Rieger JM; Macdonald TL; Watson DD; Beller GA
    Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1851-8. PubMed ID: 15591104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of the PAF-receptor from NADPH oxidase and adenylate cyclase in human neutrophils results in accelerated influx and delayed clearance of cytosolic calcium.
    Steel HC; Anderson R
    Br J Pharmacol; 2002 May; 136(1):81-9. PubMed ID: 11976271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV.
    Chini CC; Chini EN; Williams JM; Matousovic K; Dousa TP
    Kidney Int; 1994 Jul; 46(1):28-36. PubMed ID: 7933846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme.
    Silva PM; Alves AC; Serra MF; Pires AL; Silva JP; Barreto EO; Cordeiro RS; Jose PJ; Teixeira MM; Lagente V; Martins MA
    Br J Pharmacol; 2001 Sep; 134(2):283-94. PubMed ID: 11564646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The specific type IV phosphodiesterase inhibitor rolipram combined with adenosine reduces tumor necrosis factor-alpha-primed neutrophil oxidative activity.
    Sullivan GW; Carper HT; Mandell GL
    Int J Immunopharmacol; 1995 Oct; 17(10):793-803. PubMed ID: 8707444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils.
    Kyoi T; Noda K; Oka M; Ukai Y
    Life Sci; 2004 Nov; 76(1):71-83. PubMed ID: 15501481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of phosphodiesterase IV and intracellular calcium levels in human polymorphonuclear leukocytes.
    Villagrasa V; Navarrete C; Sanz C; Berto L; Perpiñá M; Cortijo J; Morcillo EJ
    Methods Find Exp Clin Pharmacol; 1996 May; 18(4):239-45. PubMed ID: 8803956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of stimulation of adenosine A2A receptors on lipopolysaccharide-induced production of reactive oxygen species by equine neutrophils.
    Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Murray TF
    Am J Vet Res; 2007 Jun; 68(6):649-56. PubMed ID: 17542699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of the adenosine A2A receptor-induced sensitization of esophageal C fibers.
    Brozmanova M; Mazurova L; Ru F; Tatar M; Hu Y; Yu S; Kollarik M
    Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(3):G215-23. PubMed ID: 26564719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells.
    Chern Y; Lai HL; Fong JC; Liang Y
    Mol Pharmacol; 1993 Nov; 44(5):950-8. PubMed ID: 8246918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury.
    Souza DG; Cassali GD; Poole S; Teixeira MM
    Br J Pharmacol; 2001 Nov; 134(5):985-94. PubMed ID: 11682446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators.
    Derian CK; Santulli RJ; Rao PE; Solomon HF; Barrett JA
    J Immunol; 1995 Jan; 154(1):308-17. PubMed ID: 7995950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
    Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
    Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.